Transcriptomic analysis performed in GBM cells reveals that aberrant EGFR/EGFRvIII signaling leads to up-regulation of the expression of genes that are target of the c-MYC oncogene through a complex and interconnected network [62]. The gene discussed is MYC; the disease is glioblastoma.